Reduced duration adjuvant trastuzumab in the treatment of patients with HER2-positive breast cancer: a meta-analysis of randomised controlled non-inferiority trials including IPD d... by Roberto D’Amico, Valentina Guarneri, PierFranco Conte, Heikki Joensuu, Xavier Pivot, Vassilis Georgoulias, Louise Hiller, Janet A Dunn, Mubarak Patel, Teppo Huttunen, Helena M Earl, Dora Hatzidaki, Jean E Abraham, David Miles, David A Cameron, Andrew M Wardley

Get full text